HUN, US4470111075

Huntsman stock gained 3.63 percent after UBS cut its target

Published on 10/06/2026 at 10:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UBS kept a Neutral rating and lowered its Huntsman target from USD 10.00 to USD 9.00 on October 5. Q2 revenue reached USD 1.7 billion, up from USD 1.5 billion.

HUN, US4470111075, Illustration mit AI erstellt.
HUN, US4470111075, Illustration mit AI erstellt.

Huntsman stock gained 3.63 percent to USD 8.84 on the NYSE on October 5, 2026, while UBS lowered its price target from USD 10.00 to USD 9.00. The move leaves the chemicals producer balancing a proposed merger with Olin against weaker European demand and elevated leverage concerns.

UBS lowers target to USD 9.00

According to MarketBeat on October 5, 2026, UBS maintained a Neutral rating and reduced its target from USD 10.00 to USD 9.00. The cut came as Huntsman traded near its 52-week low of USD 7.30 and placed the new target 1.8 percent above the USD 8.84 reference price.

MarketBeat also reported a Hold consensus based on 15 analyst ratings, with an average target of USD 11.62. That average target lies 31.4 percent above USD 8.84, although the spread between the latest UBS view and the wider consensus shows how differently analysts assess the recovery path.

Q2 revenue reaches USD 1.7 billion

Huntsman's investor-relations page lists second-quarter 2026 revenue of USD 1.7 billion, compared with USD 1.5 billion in the prior-year period. Adjusted EBITDA reached USD 120 million versus USD 74 million, giving the company a stronger operating result even as its adjusted net loss remained at USD 0 million compared with adjusted net income of USD 34 million in the prior-year period, according to Huntsman.

The second-quarter figures matter because the earnings improvement has not removed balance-sheet pressure. Investing.com reported on October 2, 2026, that Jefferies kept a Buy rating but cut its target from USD 16.00 to USD 11.00, citing soft European demand, rising gas costs and winter-related risk.

Merger still shapes the recovery case

On September 11, 2026, Huntsman and Olin said the U.S. Hart-Scott-Rodino waiting period for their proposed merger had expired. The release said the transaction still required additional regulatory approvals, so the combination remains an execution issue rather than a completed event.

The next measurable checkpoint is the third-quarter report. Investing.com lists October 29, 2026 as the next earnings date, giving investors a scheduled test for demand, margins and merger-related progress.

Stock stays near yearly low

Huntsman was last at USD 8.84 on the NYSE on October 5, 2026 at 4:02 p.m. ET, with a session range of USD 8.34 to USD 8.97. Its 52-week range was USD 7.30 to USD 16.09, while market capitalization stood at USD 1.6 billion and volume reached 4,758,766 shares.

Huntsman stock facts

  • Company: Huntsman Corporation
  • ISIN: US4470111075
  • Ticker: HUN
  • Trading venue: NYSE
  • Price (as of October 5, 2026, 4:02 p.m. ET): USD 8.84
  • Market capitalization: USD 1.6 billion (as of October 5, 2026)
  • 52-week range: USD 7.30-16.09 (as of October 5, 2026)
  • Sector / Industry: Basic Materials / Chemicals

Upcoming dates for Huntsman stock

  • October 29, 2026: Third-quarter earnings report

More news and analyses on Huntsman stock

Disclaimer...

en | US4470111075 | HUN | boerse | 70240589 | bgmi